Third-line treatment in metastatic renal cell carcinoma and bone metastases

被引：0
|
作者：
Heng, Daniel Y. C. [1 ]
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2015年 / 9卷 / 7-8期
关键词：
D O I：
10.5489/cuaj.3238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] Third-line Therapy for metastatic Renal cell carcinoma
    Rexer, H.
    ONKOLOGE, 2011, 17 (12): : 1161 - 1162
  • [2] Third-line Therapy for metastatic Renal Cell Carcinoma
    Rexer, H.
    UROLOGE, 2011, 50 (10): : 1319 - 1321
  • [3] Third-line dovitinib in metastatic renal cell carcinoma
    Schmidinger, Manuela
    LANCET ONCOLOGY, 2014, 15 (03): : 245 - 246
  • [4] Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma
    Iacovelli, Roberto
    Santini, Daniele
    Rizzo, Mimma
    Felici, Alessandra
    Santoni, Matteo
    Verzoni, Elena
    Masini, Cristina
    Massari, Francesco
    Calvani, Nicola
    Mosca, Alessandra
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (7-8): : 263 - 267
  • [5] ACTIVITY OF SUNITINIB AS THIRD-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) (JAPAN)
    Nozawa, M.
    Mochida, Y.
    Nishigaki, K.
    Nagae, S.
    Uemura, H.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I11 - I11
  • [6] Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Marsili, Stefania
    Pascucci, Alessandra
    Sciandivasci, Angela
    de Rubertis, Giovanni
    Barbanti, Gabriele
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    ANTI-CANCER DRUGS, 2007, 18 (07) : 817 - 820
  • [7] Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
    Roberto, Michela
    Bassanelli, Maria
    Iannicelli, Elsa
    Giacinti, Silvana
    D'Antonio, Chiara
    Aschelter, Anna Maria
    Marchetti, Paolo
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [8] Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Wells, J. Connor
    Stukalin, Igor
    Norton, Craig
    Srinivas, Sandy
    Lee, Jae Lyun
    Donskov, Frede
    Bjarnason, Georg A.
    Yamamoto, Haru
    Beuselinck, Benoit
    Rini, Brian I.
    Knox, Jennifer J.
    Agarwal, Neeraj
    Ernst, D. Scott
    Pal, Sumanta K.
    Wood, Lori A.
    Bamias, Aristotelis
    Alva, Ajjai S.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2017, 71 (02) : 204 - 209
  • [9] Efficacy of treatment beyond third-line (3L) in metastatic clear-cell renal cell carcinoma (mccRCC).
    Guida, Annalisa
    Le Teuff, Gwenael
    Silva, Carolina Alveosta
    Blameble, Emeline Colomba
    Salviat, Flore
    Baciarello, Giulia
    Derosa, Lisa
    Loriot, Yohann
    Fizazi, Karim
    Di Palma, Mario
    Massard, Christophe
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Targeted treatment beyond third-line in metastatic Renal Cell Carcinoma (mRCC): Single center outcome of 22 patients
    Vallet, S.
    Hoefner, T.
    Pahernik, S.
    Tosev, G.
    Hadaschik, B.
    Duensing, S.
    Hohenfellner, M.
    Jaeger, D.
    Gruellich, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 91 - 91
12345